x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

AI For Pharma Growth

Dr Andree Bates

AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to

technology

All Episodes

26:56

E127 | Who is using your face? Find out with AI

AI For Pharma Growth ·

2024/08/21

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of synthetic media and its far-reaching consequences across society. They discuss the far-reaching potential ramifications of deep fakes, including case

en

25:51

E126 | The impact of RAG and LLMs on data processing...

AI For Pharma Growth ·

2024/08/14

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to verify facts. Vinoth explains how the use of retrieval-augmented generation (RAG) can help improve the accuracy and relevance of LLM outputs. RAG models

en

23:20

E125 | Using AI to power early detection and provide...

AI For Pharma Growth ·

2024/08/07

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial calcification detection products. Navid & Andree discuss the potential of AI in oncology and cardiology, highlighting the significance of CureMetrix’s FDA

en

29:58

E124 | How AI is being used to tackle global health...

AI For Pharma Growth ·

2024/07/31

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing tech into healthcare, overcoming limited data and infrastructure, the need for collaboration, addressing systemic healthcare issues, and ensuring

en

27:26

E123 | How AI is driving improved clinical, patient,...

AI For Pharma Growth ·

2024/07/24

In this episode of AI For Pharma Growth, Dr. Andree Bates talks to Dr Andrew Rut, CEO of Metadvice, about how AI is at the forefront of improvements to the pharmaceutical industry. Metadvice uses neural networks to enable clinicians to handle patients faster and with greater accuracy. It utilises both synthetic and real data to achieve an incredibly high level of accuracy whilst following all medical guidelines. They discuss the importance of technology in improving the pharma industry,

en

29:06

E122 | Encouraging AI Adoption in Teams

AI For Pharma Growth ·

2024/07/17

In this episode of AI For Pharma Growth, Dr. Andree Bates explores the pivotal role of AI in boosting team productivity within pharmaceutical companies, alongside Tim Cakir, CEO of TaskDrive. Tim's insights stem from his background as a growth consultant, driving TaskDrive's evolution towards AI-augmented virtual assistants and achieving remarkable efficiency gains. Founded with a focus on transforming how teams operate, they integrate advanced AI technologies to streamline tasks and improve

en

36:14

E121 | Predicting The Future With AI

AI For Pharma Growth ·

2024/07/09

In this episode, Dr. Andree Bates speaks with Jordan Miller, Founder of Satori, an open-source, decentralised AI prediction network. The project integrates AI and machine learning to enhance predictive capabilities. Jordan has spent the last decade building a worldwide prediction AI network and the past two years bringing it to life. His career as a lead developer, with a background in Business Intelligence, has equipped him with the skills needed to build the initial minimum viable version of

en

34:57

E120 | Can Healthcare Be Made More Accessible and...

AI For Pharma Growth ·

2024/07/02

In this episode, Dr. Andree Bates speaks with Professor Shafi Ahmed and discusses how innovation and disruptive thinking can transform healthcare, making it more accessible and affordable for everyone. Professor Shafi Ahmed is a renowned surgeon and co-founder of Medical Realities, a company pioneering the use of virtual and augmented reality in medical education and training. In this episode you'll discover: Professor Ahmed's motivation for founding Medical Realities and focusing on innovative

en

30:13

E119 | How to use AI for Visual Inspection and...

AI For Pharma Growth ·

2024/06/25

In this episode, Dr. Andree Bates speaks with Tristan Salomon, Founder and CEO of Axom, a company specialising in advanced AI solutions for the pharmaceutical industry. Tristan Salomon has a rich background in developing and implementing AI technologies to enhance manufacturing processes. His expertise lies in creating innovative solutions that improve quality control and traceability, ensuring compliance and efficiency in the pharma sector. In this episode, you'll discover: Tristan's

en

24:47

E118 | How To Use AI To Prevent Health Issues In...

AI For Pharma Growth ·

2024/06/18

In this episode, Dr. Andree Bates speaks with Johannes Kraus, Co-Founder of YOUTH HealthTech. As a former physical therapist Johannes experienced patients suffering and approaching him every day, barely able to treat their diseases without the ability to properly follow their prevention. He founded YOUTH to prevent diseases by focusing on early detection, leveraging data from smartphones and utilising AI to give a diagnosis in under two minutes. YOUTH’s goal is to control and prevent chronic

en

34:15

E117 | Bringing The Human Body Into The Digital World

AI For Pharma Growth ·

2024/06/11

Today Dr Andree Bates chats with Dr Giulio Rognini, Head of Partnerships at Metaphysiks, about how Metaphysiks is revolutionising the world of haptic feedback. Metaphysiks is leading the charge in blending human sensation with the digital realm through their innovative neuro-haptic technology. They’ve even developed the world’s first proprietary neuro-haptic skin – a true game-changer in immersive experiences. With a decade of experience in research and development, Dr Rognini brings a wealth of

en

22:16

E116 | How AI Is Unlocking Multi-Omics Data

AI For Pharma Growth ·

2024/06/04

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Abishek Jha, Co-Founder and CEO of Elucidata, which cleans and links biomedical data at scale. They advocate for a data-centric approach to AI, arguing that clean data is more valuable than copious data. In this episode, you will learn: How Elucidata’s sources and processes data The problems they solve for biopharma companies How they’re structuring biological data with their biomedical data platform, Polly For more

en

28:14

E115 | How To Use AI To Increase Patient Adherence

AI For Pharma Growth ·

2024/05/28

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eric Doherty, who has worked in the pharmaceutical industry for 33 years and also in healthcare data AI for 4 years. He is the President of PERSOWN, Inc., a medical device company that is developing the next generation of instant Point-of-Care (POC) diagnostic testing, using electro-chemical biosensors. They speak about how AI is improving patient adherence by increasing medication uptake and recording data to prevent excessive

en

29:20

E114 | The Next Evolution In Foundational Data Set...

AI For Pharma Growth ·

2024/05/21

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Philipp Lorenz, Chief Technology Officer of Basecamp Research. Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. They match and refine novel proteins for your exact industrial or therapeutic and diagnostic applications. In this episode you will learn: How Basecamp collected diverse biological sequence data How they partner with Nature Parks across five continents Why

en

26:59

E113 | Using AI To Uncover Legal And Regulatory Risks

AI For Pharma Growth ·

2024/05/14

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Matt Van Itallie, Founder and CEO of Sema. Sema is a software company that is squarely focused on understanding and improving tech. They build tools that bring technologists and non-technologists together. They’ve successfully managed the risks of Gen AI whilst capturing the benefits in the software development life cycle. The rapid advancement of Gen AI has regulators around the world reaching to understand, control and

en

41:11

E112 | Game On For Blockbusters, Novel MOAs, And...

AI For Pharma Growth ·

2024/05/07

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Ben Weintraub, the President of InThought Research and Doug Foster, Creator of the inVision software. inThought Research is a leading pharmaceutical and life science consulting firm providing analytical, forecasting, and competitive intelligence services to support strategic and tactical decisions of biopharmaceutical and financial firms. inVision is aimed at offering clients a streamlined interface for their business

en

27:10

E111 | The role of AI to create access to better...

AI For Pharma Growth ·

2024/04/30

Today Dr Andree Bates talks to Patricia Gall, Founder and CEO of MindSpark 360, about the organisation's pivotal role in advancing mental health innovation. MindSpark 360 operates as a structured programme, fostering open communication among all stakeholders in the mental health sector. Whether collaborating with corporations prioritising employee well-being or partnering with organisations driving new technologies and treatments for patients, MindSpark360 aims to facilitate sustainable

en

28:37

E110 | How Pharmacies can Leverage AI for Improved...

AI For Pharma Growth ·

2024/04/23

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eunice Wu, Co-Founder and CEO of Asepha. Asepha helps Pharmacies to work efficiently and faster through specific and intelligent tests on their AI models. Eunice explains the potential of AI in revolutionising pharmacy operations and patient care, particularly through improved speed and accuracy in repetitive tasks. Eunice points out the value of context in AI produced results and the bridge between current and evolving models

en

31:21

E109 | How AI is Enhancing HTA in Precision Oncology

AI For Pharma Growth ·

2024/04/16

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by haemato-oncologist Niamh Boyle, who works in the Health Economic Evaluation of Precision Medicine in Cancer research project, University of South Wales. Andree and Niamh discuss the use of AI in research methodologies and processes related to precision oncology. They also talk about how Health Technology Appraisal (HTA) bodies, such as the National Institute for Health and Care Excellence (NICE) implement and analyse AI in

en

23:19

E108 | Using AI to Assess Brain Health more...

AI For Pharma Growth ·

2024/04/09

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Liam Kaufman, Vice President of Cambridge Cognition. Andree and Liam talk about the use of AI during Central Nervous System (CNS) clinical research trials. They delve into how brain health and neural pathways can be explored and analysed, solely with the use of modern scientific technology. Cambridge Cognition’s work has been pivotal in CNS examination and treatment. Liam explains how far investigative methods in this field

en

209 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs